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Topic Signiﬁcance & Study Purpose/Background/Rationale:
The Blood andMarrow Transplant (BMT) patient population is
highly susceptible to acquiring a Clostridium difﬁcile (c. diff)
infection. The prolonged neutropenic status causes c. diff in-
fections to be more severe and longer lasting in this patient
population (Rev Inst Med Trop Sao Paulo. 2014 Jul;56(4):325-
31). On average, the cost of a Hospital Acquired Infection (HAI)
of c. diff is $11,285 per incident (JAMA Intern Med 2013;
173(22)2039-2046). The current practice of sanitizing with
bleach wipes with all patients has minimal effect on c. diff
rates (Clin Infect Dis. (2000) 31 (4): 995-1000).
Methods, Intervention, & Analysis: Starting November
2013, the University of Minnesota Health Adult BMT unit
experienced an increased prevalence of c. diff in the inpatient
population. As a result, the unit switched their sanitizing
practices to universally sanitizing with a hypochlorite solu-
tion. Previously, only rooms of patients testing positive for a
c. diff infection were sanitized with a hypochlorite solution.
This switch did not result in a signiﬁcant drop in c. diff rates
per one thousand patient days. In February, a silver based
solution (Steriplex SD & Steriplex 360) was adopted unit
wide to replace the hypochlorite solution. The use of all other
sanitizing products was discontinued. C. diff rates were
measured by patient lab reports.
Findings & Interpretation: Findings demonstrated that the
switch to silver basedwipes from bleach based wipes reduced
c. diff infection rates among the BMT population, as demon-
strated by the drop in the rate of active c. diff from 5.5/1000
patient days to 0/1000 patient days. The current hospital
practice to reduce the transmission of active c. diff infection is
the use of bleach based wipes. Implications of the study
include: ongoing advocacy of improved infection prevention
measures in the care of BMT patients, further conversations
with the infection control department about c. diff infection
control practices in the BMT population, as well as consider-
ation for switching disinfection products hospital wide.
Discussion & Implications: Based on these ﬁndings, we
have switched solely to sanitizing with the silver-based so-
lution. We recommend the use of this solution to the
outpatient BMT clinic. This practice would be beneﬁcial in
protecting all patient populations including those with he-
matological/oncological conditions.569
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Topic Signiﬁcance & Study Purpose/Background/Rationale:
Hematopoietic transplantation is a complex procedure.
Excellent education and discussionwith patients and family is
imperative because of increasingly complicated clinical and
psychosocial management of their care. In the early steps of
pre-transplant preparation, before admission, it is important
to initiate discussion with the patient and family about
discharge teaching. This was important when moving autol-
ogous transplant in outpatient day hospital.To discuss process of patient/caregiver evaluation and
caregiver support during patient day hospital visits: 1) the
implementation of Pre transplant Caregiver education; 2)
identify speciﬁc content areas for pre-transplant teaching; 3)
additional methods of teaching involving both patient and
caregiver.
Methods, Intervention, & Analysis: A group was formed to
develop Day Hospital HCT Discharge Teaching to: 1)
improve patient/family caregiver education about outpa-
tient HCT multiple myeloma in the day hospital; 2) create
content and develop methods for patient & caregiver edu-
cation in preparation for admission to the Day Hospital and
3) develop and adminster satisfaction survey of new OPD
transplant process.
Findings & Interpretation: A task force of staff nurses, nurse
practitioner, nurse educators, nursing leaders, case managers,
and clinical social workerwas assembled to develop caregiver
education which included the caregiver attending a group
class facilitated by a nurse coordinator; caregiver contract;
and complete symptom management forms. In addition,
nurse coordinators and day hospital staff review speciﬁc
content for HCT patient care, common medications and side
effects, expected transplant related symptoms, discharge is-
sues which include VAD care, infection precautions, dietary
restrictions, home preparation, clinic routine, and long term
survivorship topics with the caregiver. With the pre-trans-
plant education, patient and caregiver satisfactionwas high at
day of transplant (caregiver 90.3%, patient 91.8%) and at day of
discharge (patient only 90%); with these efforts, it achieved a
decrease in the HCT number of length of stay days from 21
days to 14 days. Ninety two percent of patients (n¼12)
received their stem cells in an outpatient setting.
Discussion & Implications: There was improved coopera-
tion between physician/mid-level/nursing teams resulting in
timely and efﬁcient care and cooperation between outpa-
tient and inpatient; patient obtained prescribed medication
100% and patient expressed quality of life is better main-
tained. The institutional commitment to the program has
promoted seamless care.570
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Topic Signiﬁcance & Study Purpose/Background/Rationale:
Advances in the design of CVCs has led to a variety of features
that increase the functionality of CVCs used in the care of BMT
patients. Examples of these features include: power injection
of contrast media, central venous pressure (CVP) monitoring,
apheresis procedures including stem cell collection, plasma
exchange and extracorporeal photopheresis. However,
matching the right CVC with the individual treatment re-
quirements for BMT patients can be a challenge. For example,
CVC’s composed of polyurethane are not recommended for
infusion containing high concentrations of alcohol (e.g., un-
diluted etoposide). At our institution, an opportunity for
improvement was identiﬁed due to an increase in occurrences
of inappropriate CVC selection. The decision to develop a
nurse-initiated protocol was based on the knowledge of
infusion therapy.
Abstracts / Biol Blood Marrow Transplant 21 (2015) S374eS390 S381Methods, Intervention, & Analysis: In order to optimize the
best outcome of selection and placement of the right CVC for
BMT recipients, a nurse-initiated protocol for CVC selection
was developed. CVC options and patient risk factors that
nurses utilize in the care and maintenance of CVCs. The CVC
selection protocol is based on the speciﬁc requirements of
the patient’s road map for transplant. Application of manu-
facturer’s guidelines for each device and collaboration by a
multidisciplinary team were used to identify the best CVC
choice for the patient with reference to the patient’s planned
therapies. For example:Autologous BMT
Patient Criteria
CVC Type
Standard mobilization
and collection
No undiluted
etoposide
High ﬂow temporary CVC for mobilization/
collection
Double lumen power injectable peripherally
inserted central catheter (PICC)To implement the protocol, the BMT RN Coordinator
starts with a review of the patient’s road map for transplant
in collaboration with the BMT pharmacist. After the review
the RN selects the appropriate CVC based on the protocol
table that pairs the correct CVC with patient criteria. Once
the selection is made the BMT RN Coordinator enters the
order for the CVC type into the electronic medical record. The
order is then accessed by the surgeon, interventional radi-
ologist and/or nurse placing the CVC.
Findings & Interpretation: N/A
Discussion & Implications: The goal of this quality
improvement project is to eliminate occurrences of inap-
propriate CVC placement in autologous and allogeneic
transplant recipients.571
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Topic Signiﬁcance & Study Purpose/Background/Rationale:
It has been observed (Blood, 5/01; Blood 10/2012) that
unrelated bone marrow and peripheral blood stem cell
donors experience similar levels of mild/moderate
discomfort post donation with bone marrow donors having
a longer period of discomfort post donation. FACT standards
now recommend long-term follow-up of donors. This cen-
ter cares for approximately 70 related donors a year. Pre-
vious to this project, nurses assessed the donors (both
apheresis and marrow) the day post donation, and
instructed them to call if they had questions thereafter. To
improve follow up, nurses caring for the donors initiated a
trial to conduct a telephone interview assessment of all
donors a week after their ﬁnal Clinic visit.
Methods, Intervention, & Analysis: In October 2013 a pilot
was undertaken to actively assess related donors post
donation. A questionnaire was vetted and approved to be
used in telephone follow up by the Clinic RN who had cared
for the donor. All donors were called 1 week following
donation and monitored for symptoms of discomfort. If anysymptoms were reported, follow up continued until
resolved. This pilot was also used as a quality audit tool,
asking the donors if there was anything we could have told
them that would have been helpful, and if there was any-
thing they thought we could improve upon.
Findings & Interpretation and Discussion & Implications:
At the time of this submission, we have made 35 follow up
calls; of those 24 had no symptoms, 8 reported symptoms of
discomfort and 3 were unable to be contacted. Over 1/4 of the
patients had mild to moderate discomfort at one week post
donation. Follow up contact with donors provides an on-
going link with the clinical team and yields useful informa-
tion for addressing the needs of donors.572
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Topic Signiﬁcance & Study Purpose/Background/Rationale:
Multidisciplinary rounds (MR) are a standard model used in
hospitals. Our Transplant Center performs approximately 500
Hematopoietic Cell Transplants (HCT) annually. Care of the
HCT patients has moved from the inpatient setting to the
ambulatory clinic. In the clinic, complex care is managed for
HCT patients coordinating clinical care, nutritional needs,
medication management, psych-social issues and scheduling.
Labs, radiology, medications, pathology, and symptom man-
agement require close observation and review at 24 hour in-
crements. This complex patient care management is best
implemented with the utilization of MR.
Methods, Intervention, & Analysis: Each patient is followed
by a team comprised of an Attending MD, Primary Care
Provider, RN, Pharmacist, Registered Dietician, Social Worker
and Team Coordinator. The team meets daily for 30 minutes
to review current status of all patients, each discipline
providing input and making suggestions for care adjust-
ments needed. There is full team discussion of any
issuesdmedical, nursing, social, ﬁnancial, compliancedthat
impact care on any level. Anticipated workups that need
orders, upcoming procedures that require teaching such as
chemotherapy or dressing changes, as well as any recent
pertinent results are also brieﬂy discussed so orders and
appointments can be obtained in a timely fashion.
Findings & Interpretation: Daily MR in the outpatient HCT
clinic has been found to provide an opportunity to make
adjustments to the patient’s care and allow for more HCT
care to be performed in the outpatient setting as evidenced
the ability to performHCT sometimes solely in the outpatient
setting, with no admission to the hospital. Satisfaction with
this care is evidenced by Patient Satisfaction scores.
Discussion & Implications: The inpatient model of daily
MR can be replicated in the outpatient HCT setting. A
Team RN acting as the care coordinator facilitates the
outpatient care and serves as the patient voice. This can
safely increase the time a patient is able to spend outside
the hospital which decreases costs and increases quality of
life.
